A 2587 New Jersey General Assembly · 2024-2025 Regular Session

Prohibits certain steering and marketing practices involving dispensing of prescription drugs and drug samples.

This bill prohibits drug manufacturers, pharmacies, wholesalers, and healthcare practitioners from using devices, kiosks, or machines to steer patients to specific pharmacies or restrict their pharmacy choice when dispensing prescriptions or drug samples. It requires explicit patient consent before transmitting personal health information to a preferred pharmacy and bans using patient data for marketing without authorization. Violations carry penalties of at least $100,000 for companies and $250 for practitioners per offense. The bill also aligns with federal privacy rules (HIPAA) by requiring disclosure of insurance charges related to data sharing and prohibiting the sale of patient medical information for promotional purposes.
Bill status in committee 1 of 4 stages cleared
Introduction
Jan 2024
Committee Review
Floor Vote
Governor
Introduced Jan 9, 2024 Last action Jan 9, 2024
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
1
Key actions
0
Committee
0
Jan 9, 2024
Introduced
Introduced in the Assembly, Referred to Assembly Health Committee
lower
1 primary · 0 co-sponsors

Sponsors

Role
Legislator
Party
State
District
P
Photo of Jessica Ramirez
Jessica Ramirez
DDemocratic
NJ
32